Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BETR | CSE | CAD | Delayed | |
BETRF | OTC Markets | USD | Delayed | |
BETR | CBOE Canada | CAD | Real-time |
BetterLife Pharma Inc. is a biopharmaceutical company. The Company primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001 is a non-hallucinogenic Lysergic Acid Diethylamide (LSD) derivative. BETR-001 mimics the projected therapeutic properties of LSD without causing its undesirable side effects such as hallucinations and cardiac toxicity. BETR-001 is a therapy to treat debilitating psychiatric disorders with high unmet need, such as major depressive disorder and anxiety disorders; as well as neurological disorders such as neuropathic pain. BETR-002 is a formulation of a derivative of dihydrohonokiol, a known anti-anxiety compound for treatment of benzodiazepine dependency, anxiety and spasticity. The Company also owns a drug candidate for the treatment of viral infections such as COVID-19. The Company’s subsidiaries include MedMelior Inc. and BetterLife Europe Pharmaceuticals AG.
Name | Age | Since | Title |
---|---|---|---|
Ahmad Doroudian | 62 | 2007 | Founder, CEO & Chairman |
Wolfgang Renz | 53 | 2015 | Independent Director |
Robert James Metcalfe | 82 | 2020 | Independent Director |
Ralph Anthony Pullen | 76 | 2020 | Director |
Mark Swaim | - | - | Member of Advisory Board |
Argel Aguilar-Valles | - | 2022 | Member of Scientific Advisory Board |
John D. McCorvy | - | 2022 | Member of Scientific Advisory Board |
Adam Halberstadt | - | 2022 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review